Thornton Michael Milos
SEC CIK 1706297 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NDRA | ENDRA Life Sciences Inc. | CTO | 34.1K | $46.0K | — | 6 | 2021-01-28 | 2023-05-18 |
Most active insiders at NDRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Jacroux Richard | CFO | — | — |
| 2 | Basenese Lou | Dir | — | — |
| 3 | Harsh Michael | Dir | — | — |
| 4 | Tokman Alexander Y | CEO, Dir | — | — |
| 5 | DIGIANDOMENICO ANTHONY | Dir | — | — |
Thornton Michael Milos made no open-market trades at NDRA in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-22 | 2023-05-18 | NDRA | ENDRA Life Sciences Inc. | Thornton Michael Milos | CTO | P - Purchase | $1.65 | +15.0K | 34.1K | +78% | +$24.8K | |
| 2022-12-13 | 2022-12-09 | NDRA | ENDRA Life Sciences Inc. | Thornton Michael Milos | CTO | P - Purchase | $3.40 | +1,500 | 19.1K | +9% | +$5,100 | |
| 2022-08-24 | 2022-08-22 | NDRA | ENDRA Life Sciences Inc. | Thornton Michael Milos | CTO | P - Purchase | $0.27 | +20.0K | 352.8K | +6% | +$5,400 | |
| 2022-05-31 | 2022-05-26 | NDRA | ENDRA Life Sciences Inc. | Thornton Michael Milos | CTO | P - Purchase | $0.21 | +25.0K | 332.8K | +8% | +$5,250 | |
| 2022-05-23 | 2022-05-18 | NDRA | ENDRA Life Sciences Inc. | Thornton Michael Milos | CTO | P - Purchase | $0.22 | +25.0K | 307.8K | +9% | +$5,500 | |
| 2021-09-22 | 2021-01-28 | NDRA | ENDRA Life Sciences Inc. | Thornton Michael Milos | CTO | A - Grant | $0.00 | +22.8K | 316.5K | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations